---
pmid: '40067145'
title: The Ulcerative Colitis-Associated Gene NXPE1 Catalyzes Glycan Modifications
  on Colonic Mucin.
authors:
- Humeidi R
- Oshiro-Rapley N
- Gu X
- An JS
- Ananthakrishnan AN
- Creasey EA
- Daly MJ
- Schreiber SL
- Graham DB
- Seyedsayamdost MR
- Xavier RJ
journal: J Am Chem Soc
year: '2025'
full_text_available: false
pmcid: PMC12076216
doi: 10.1021/jacs.5c00769
---

# The Ulcerative Colitis-Associated Gene NXPE1 Catalyzes Glycan Modifications on Colonic Mucin.
**Authors:** Humeidi R, Oshiro-Rapley N, Gu X, An JS, Ananthakrishnan AN, Creasey EA, Daly MJ, Schreiber SL, Graham DB, Seyedsayamdost MR, Xavier RJ
**Journal:** J Am Chem Soc (2025)
**DOI:** [10.1021/jacs.5c00769](https://doi.org/10.1021/jacs.5c00769)
**PMC:** [PMC12076216](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12076216/)

## Abstract

1. J Am Chem Soc. 2025 Mar 26;147(12):10618-10628. doi: 10.1021/jacs.5c00769.
Epub  2025 Mar 11.

The Ulcerative Colitis-Associated Gene NXPE1 Catalyzes Glycan Modifications on 
Colonic Mucin.

Humeidi R(1)(2)(3), Oshiro-Rapley N(2)(3), Gu X(2)(3), An JS(4), Ananthakrishnan 
AN(5)(6), Creasey EA(3), Daly MJ(2)(7), Schreiber SL(2)(8), Graham DB(2)(3)(9), 
Seyedsayamdost MR(4)(10), Xavier RJ(2)(3)(9).

Author information:
(1)Program for Chemistry & Chemical Biology, Harvard Medical School, Boston, 
Massachusetts 02115, United States.
(2)Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02141, United 
States.
(3)Department of Molecular Biology, Massachusetts General Hospital and Harvard 
Medical School, Boston, Massachusetts 02114, United States.
(4)Department of Chemistry, Princeton University, Princeton, New Jersey 08544, 
United States.
(5)Department of Medicine, Harvard Medical School, Boston, Massachusetts 02114, 
United States.
(6)Division of Gastroenterology, Massachusetts General Hospital, Boston, 
Massachusetts 02114, United States.
(7)Analytic and Translational Genetics Unit, Massachusetts General Hospital and 
Harvard Medical School, Boston, Massachusetts 02114, United States.
(8)Department of Chemistry & Chemical Biology, Harvard University, Cambridge, 
Massachusetts 02138, United States.
(9)Center for the Study of Inflammatory Bowel Disease, Massachusetts General 
Hospital and Harvard Medical School, Boston, Massachusetts 02114, United States.
(10)Department of Molecular Biology, Princeton University, Princeton, New Jersey 
08544, United States.

Colonic mucus forms a first line of defense against bacterial invasion while 
providing nutrition to support coinhabiting microbes in the gut. Mucus is 
composed of polymeric networks of mucin proteins, which are heavily modified 
post-translationally. The full compendium of enzymes responsible for these 
modifications and their roles in health and disease remain incompletely 
understood. Herein, we determine the biochemical function of NXPE1, a gene 
implicated in ulcerative colitis (UC), and demonstrate that it encodes an 
acetyltransferase that modifies mucin glycans. Specifically, NXPE1 utilizes 
acetyl-CoA to regioselectively modify the mucus sialic acid, 
5-N-acetylneuraminic acid (Neu5Ac), at the 9-OH group to generate 9-O-acetylated 
Neu5Ac (Neu5,9Ac2). We further demonstrate that colonic organoids derived from 
donors harboring the missense variant NXPE1 G353R, which is protective against 
UC, exhibit severely impaired acetylation of Neu5Ac on mucins. Together, our 
findings support a model in which NXPE1 masks the alcohols of mucus sialoglycans 
via acetylation, which is important for modulating mucus barrier properties that 
limit interactions with commensal microbes.

DOI: 10.1021/jacs.5c00769
PMCID: PMC12076216
PMID: 40067145 [Indexed for MEDLINE]

Conflict of interest statement: CONFLICT OF INTEREST R.J.X. is co-founder of 
Jnana Therapeutics, Scientific Advisory Board member at Nestl√© and Magnet 
BioMedicine, and Board Director at MoonLake Immunotherapeutics; these 
organizations had no roles in this study. All other authors declare no conflicts 
of interest.
